BYCEMMA Trademark

Trademark Overview


On Monday, February 3, 2020, a trademark application was filed for BYCEMMA with the United States Patent and Trademark Office. The USPTO has given the BYCEMMA trademark a serial number of 88783462. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Amgen Inc.. The BYCEMMA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders
bycemma

General Information


Serial Number88783462
Word MarkBYCEMMA
Filing DateMonday, February 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 2 GRANTED
Thursday, September 16, 2021SOU EXTENSION 2 FILED
Thursday, September 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 4, 2021SOU EXTENSION 1 GRANTED
Tuesday, May 4, 2021SOU EXTENSION 1 FILED
Tuesday, May 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2020ASSIGNED TO LIE
Tuesday, August 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2020NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2020NON-FINAL ACTION WRITTEN
Wednesday, March 11, 2020ASSIGNED TO EXAMINER
Friday, February 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 6, 2020NEW APPLICATION ENTERED